Japan's Nakashima To Benefit From Government R&D Pilot Project
This article was originally published in PharmAsia News
Executive SummaryNakashima Medical is one of the Japanese firms receiving government research and development help in a pilot project designed to increase the nation's technology advantage
You may also be interested in...
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.